Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $0 |
| FY2017, ended Dec 31, 2017 | $0 |
| FY2018, ended Dec 31, 2018 | $72.2B |
| FY2019, ended Dec 31, 2019 | $76.1B |
| FY2020, ended Dec 31, 2020 | $73.2B |
| FY2021, ended Dec 31, 2021 | $73.7B |
| FY2022, ended Dec 31, 2022 | $98.4B |
| FY2023, ended Dec 31, 2023 | $87.5B |
| FY2024, ended Dec 31, 2024 | $75.6B |
| FY2025, ended Dec 31, 2025 | $72.5B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $72.8B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $39.8B |
| FY2017, ended Dec 31, 2017 | $41.8B |
| FY2018, ended Dec 31, 2018 | $48.6B |
| FY2019, ended Dec 31, 2019 | $154B |
| FY2020, ended Dec 31, 2020 | $160B |
| FY2021, ended Dec 31, 2021 | $174B |
| FY2022, ended Dec 31, 2022 | $181B |
| FY2023, ended Dec 31, 2023 | $195B |
| FY2024, ended Dec 31, 2024 | $247B |
| FY2025, ended Dec 31, 2025 | $275B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $282B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.87B | $3.56B |
| FY2017, ended Dec 31, 2017 | $2.24B | $3.62B |
| FY2018, ended Dec 31, 2018 | $2.64B | $3.24B |
| FY2019, ended Dec 31, 2019 | $5.10B | $8.44B |
| FY2020, ended Dec 31, 2020 | $8.46B | — |
| FY2021, ended Dec 31, 2021 | $5.37B | — |
| FY2022, ended Dec 31, 2022 | $6.70B | — |
| FY2023, ended Dec 31, 2023 | $5.16B | — |
| FY2024, ended Dec 31, 2024 | $3.43B | — |
| FY2025, ended Dec 31, 2025 | $5.96B | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $6.42B | — |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.19B |
| FY2017, ended Dec 31, 2017 | $2.97B |
| FY2018, ended Dec 31, 2018 | $3.85B |
| FY2019, ended Dec 31, 2019 | $4.62B |
| FY2020, ended Dec 31, 2020 | $10.2B |
| FY2021, ended Dec 31, 2021 | $5.08B |
| FY2022, ended Dec 31, 2022 | $5.92B |
| FY2023, ended Dec 31, 2023 | $7.82B |
| FY2024, ended Dec 31, 2024 | $7.55B |
| FY2025, ended Dec 31, 2025 | $7.68B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $6.30B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | — |
| FY2017, ended Dec 31, 2017 | $5.44B |
| FY2018, ended Dec 31, 2018 | $42.5B |
| FY2019, ended Dec 31, 2019 | $37.4B |
| FY2020, ended Dec 31, 2020 | $32.9B |
| FY2021, ended Dec 31, 2021 | $33.7B |
| FY2022, ended Dec 31, 2022 | $31.1B |
| FY2023, ended Dec 31, 2023 | $30.9B |
| FY2024, ended Dec 31, 2024 | $32.0B |
| FY2025, ended Dec 31, 2025 | $31.5B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $31.9B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up — since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 0 |
| FY2017, ended Dec 31, 2017 | 0 |
| FY2018, ended Dec 31, 2018 | 380M |
| FY2019, ended Dec 31, 2019 | 372M |
| FY2020, ended Dec 31, 2020 | 352M |
| FY2021, ended Dec 31, 2021 | 321M |
| FY2022, ended Dec 31, 2022 | 297M |
| FY2023, ended Dec 31, 2023 | 292M |
| FY2024, ended Dec 31, 2024 | 274M |
| FY2025, ended Dec 31, 2025 | 264M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 264M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $139M | $128M | $36.0M | — |
| FY2017, ended Dec 31, 2017 | $2.73B | $178M | $131M | — |
| FY2018, ended Dec 31, 2018 | $342M | $180M | $68.0M | $25.2B |
| FY2019, ended Dec 31, 2019 | $1.99B | $299M | $224M | — |
| FY2020, ended Dec 31, 2020 | $4.04B | $289M | $376M | — |
| FY2021, ended Dec 31, 2021 | $7.74B | $268M | $326M | — |
| FY2022, ended Dec 31, 2022 | $7.61B | $264M | $389M | — |
| FY2023, ended Dec 31, 2023 | $2.28B | $286M | $187M | — |
| FY2024, ended Dec 31, 2024 | $7.03B | $308M | $305M | — |
| FY2025, ended Dec 31, 2025 | $3.62B | $291M | $203M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.28B | — | $220M | — |
Valuation
At current price- Market Cap
- $78.8B
- P/E
- 12.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.3×
- Price / Book
- 1.8×
- EV / EBITDA
- 8.2×
Growth
Trailing 12 months- Revenue (TTM)
- $282B
- Revenue Growth YoY
- 7.8%
- Revenue CAGR 3Y
- 15.0%
- Revenue CAGR 5Y
- 11.4%
- EPS Growth YoY
- 32.6%
- Net Income Growth YoY
- 27.9%
Profitability
Trailing 12 months- Gross Margin
- 20.6%
- Operating Margin
- 3.5%
- Net Margin
- 2.3%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 15.5%
Earnings
Trailing 12 months- Net Income
- $6.42B
- EPS (diluted)
- $24.18
- EBITDA
- $12.7B
- Operating Income
- $9.96B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $6.30B
- Total Debt
- $31.9B
- Net Debt
- $25.6B
- Total Assets
- $157B
- Total Liabilities
- $114B
- Shareholders' Equity
- $42.6B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $10.3B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 2.1%
- Dividend / Share
- $6.19
- Beta (5Y)
- 0.29
Every ratio is calculated from the company’s reported figures.